Karleen Marie  Oberton net worth and biography

Karleen Oberton Biography and Net Worth

CFO of Hologic

Karleen Oberton became Hologic’s Chief Financial Officer in August 2018. She joined Hologic in 2006 as corporate controller, was promoted to Chief Accounting Officer in 2014 and joined the new Global Leadership Team in 2017. Before joining Hologic, Ms. Oberton served as senior corporate controller of lmmunogen from 2004 to 2006. Prior to that, she was a Senior Audit Manager in Ernst Young's Life Science practice and in Arthur Andersen's High Technology practice. Ms. Oberton was an active Certified Public Accountant for more than 18 years and holds a BS in Business Administration from Merrimack College. She is a member of Merrimack's Leadership Council. Ms. Oberton serves on the board of directors of AMETEK, Inc.

What is Karleen Marie Oberton's net worth?

The estimated net worth of Karleen Marie Oberton is at least $7.83 million as of January 29th, 2024. Ms. Oberton owns 103,916 shares of Hologic stock worth more than $7,833,188 as of April 21st. This net worth estimate does not reflect any other assets that Ms. Oberton may own. Additionally, Ms. Oberton receives an annual salary of $1,600,000.00 as CFO at Hologic. Learn More about Karleen Marie Oberton's net worth.

How old is Karleen Marie Oberton?

Ms. Oberton is currently 53 years old. There are 6 older executives and no younger executives at Hologic. The oldest executive at Hologic is Mr. Peter P. Dunne, Senior Vice President of Human Resources, who is 68 years old. Learn More on Karleen Marie Oberton's age.

What is Karleen Marie Oberton's salary?

As the CFO of Hologic, Inc., Ms. Oberton earns $1,600,000.00 per year. The highest earning executive at Hologic is Mr. Stephen P. MacMillan, Chairman, CEO & President, who commands a salary of $4,120,000.00 per year. Learn More on Karleen Marie Oberton's salary.

How do I contact Karleen Marie Oberton?

The corporate mailing address for Ms. Oberton and other Hologic executives is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. Hologic can also be reached via phone at (508) 263-2900 and via email at [email protected]. Learn More on Karleen Marie Oberton's contact information.

Has Karleen Marie Oberton been buying or selling shares of Hologic?

Karleen Marie Oberton has not been actively trading shares of Hologic during the past quarter. Most recently, Karleen Marie Oberton sold 14,940 shares of the business's stock in a transaction on Monday, January 29th. The shares were sold at an average price of $75.00, for a transaction totalling $1,120,500.00. Following the completion of the sale, the chief financial officer now directly owns 103,916 shares of the company's stock, valued at $7,793,700. Learn More on Karleen Marie Oberton's trading history.

Who are Hologic's active insiders?

Hologic's insider roster includes Benjamin Cohn (Insider), Sally Crawford (Director), Sean Daugherty (Insider), Scott Garrett (Director), John Griffin (General Counsel), Stephen Macmillan (CEO), Essex Mitchell (Insider), Karleen Oberton (CFO), Kevin Thornal (Insider), Peter Valenti, III (Insider), and Jan Verstreken (Insider). Learn More on Hologic's active insiders.

Are insiders buying or selling shares of Hologic?

During the last twelve months, insiders at the medical equipment provider sold shares 7 times. They sold a total of 62,736 shares worth more than $4,696,732.85. The most recent insider tranaction occured on March, 14th when Director Scott T Garrett sold 16,441 shares worth more than $1,241,295.50. Insiders at Hologic own 1.8% of the company. Learn More about insider trades at Hologic.

Information on this page was last updated on 3/14/2024.

Karleen Marie Oberton Insider Trading History at Hologic

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2024Sell14,940$75.00$1,120,500.00103,916View SEC Filing Icon  
11/1/2022Sell14,545$72.50$1,054,512.50126,811View SEC Filing Icon  
1/2/2020Sell16,348$51.73$845,682.04View SEC Filing Icon  
11/8/2018Sell1,312$41.90$54,972.8010,206View SEC Filing Icon  
11/6/2018Sell546$39.96$21,818.1610,206View SEC Filing Icon  
5/2/2018Sell12,196$40.00$487,840.0013,825View SEC Filing Icon  
11/20/2017Sell1,023$39.84$40,756.32View SEC Filing Icon  
11/8/2017Sell1,256$39.29$49,348.249,406View SEC Filing Icon  
11/6/2017Sell538$39.40$21,197.208,343View SEC Filing Icon  
7/17/2017Sell4,704$45.19$212,573.76View SEC Filing Icon  
11/21/2016Sell3,023$38.32$115,841.3613,260View SEC Filing Icon  
11/15/2016Sell1,211$36.55$44,262.0510,859View SEC Filing Icon  
11/8/2016Sell984$38.57$37,952.889,065View SEC Filing Icon  
11/7/2016Sell522$38.53$20,112.669,839View SEC Filing Icon  
10/10/2016Sell31,470$40.00$1,258,800.0017,005View SEC Filing Icon  
5/26/2016Sell4,228$33.85$143,117.808,819View SEC Filing Icon  
1/29/2015Sell18,997$30.00$569,910.00View SEC Filing Icon  
11/11/2014Sell2,609$26.30$68,616.70View SEC Filing Icon  
11/3/2014Sell12,507$26.83$335,562.81View SEC Filing Icon  
See Full Table

Karleen Marie Oberton Buying and Selling Activity at Hologic

This chart shows Karleen Marie Oberton's buying and selling at Hologic by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Hologic Company Overview

Hologic logo
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Read More

Today's Range

Now: $75.38
Low: $74.98
High: $75.62

50 Day Range

MA: $75.75
Low: $73.15
High: $78.41

2 Week Range

Now: $75.38
Low: $64.02
High: $87.88

Volume

1,288,503 shs

Average Volume

1,516,576 shs

Market Capitalization

$17.69 billion

P/E Ratio

35.73

Dividend Yield

N/A

Beta

1